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teins (DICPs) was identiﬁed in the zebraﬁsh genome. Twenty-nine distinct loci mapping to three chromosomal
regions encode receptor-type structures possessing two classes of Ig ectodomains (D1 and D2). The sequence
and number of Ig domains, transmembrane regions and signaling motifs vary between DICPs. Interindividual
polymorphism and alternative RNA processing contribute to DICP diversity. Molecular models indicate that
most D1 domains are of the variable (V) type; D2 domains are Ig-like. Sequence differences betweenD1 domains
are concentrated in hypervariable regions on the front sheet strands of the Ig fold. Recombinant DICP Ig domains
bind lipids, a property shared by mammalian CD300 and TREM family members. These ﬁndings suggest that
novel multigene families encoding diversiﬁed immune receptors have arisen in different vertebrate lineages
and affect parallel patterns of ligand recognition that potentially impact species-speciﬁc advantages.
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As the phylogenetically widely divergent species in which im-
mune receptors have been characterized increases, several major
trends can be recognized: 1) innate immune receptors have a long
evolutionary history with marked similarities in receptor structure
and function across wide phylogenetic boundaries [1], 2) primary
mediators of adaptive immunity have undergone many changes dur-
ing the evolution of vertebrates but share remarkable similarities in
basic aspects of genetic recombination (rearrangement) and clonal
selection [2] and 3) structures of receptors that mediate natural killer
(NK)-type function can vary markedly even within members of a
single class of vertebrate species (mammals) [3]. It is more difﬁcult
to recognize common features of other receptors that are classiﬁed
as immune-type because of their structural domain composition
and signaling properties. Many of these genes are encoded in multi-
gene families and exhibit patterns of structural variation that are
predicted to be associated with functional differences. It is likelywith GenBank under accession
rights reserved.that at least some receptors encoded by these genes are elements
of unrecognized receptor-signaling networks and function through
novel mechanisms. The presence of such multigene families in modern
representatives of phylogenetically important species emphasizes their
signiﬁcance. Of the various nonmammalian animal models in which
these molecules have been identiﬁed, the zebraﬁsh (Danio rerio) offers
many unique methodological advantages.
We have described variable (V) region-containing transmembrane
receptors (novel immune-type receptors [NITRs]) in zebraﬁsh and
other bony ﬁsh [4]. NITRs are the most complex family of V region-
containing immune-type receptors described thus far outside of
immunoglobulin (Ig) and T cell antigen receptors (TCRs) [5]. NITRs
function in allogeneic recognition in a manner akin to activating/
inhibitory NK receptors [6]. A direct cloning strategy [7] identiﬁed
a distantly related multigene family (modular domain immune-
type receptors [MDIRs]) [8]. Through genome scanning utilizing
MDIR and NITR Ig domain sequences, an additional multigene family
encoding diverse Ig domain-containing proteins (DICPs) was identi-
ﬁed. We describe herein the genomic organization, sequence com-
plexity and predicted protein structures of the DICPs in zebraﬁsh,
which likely are unique to bony ﬁsh. We also demonstrate that re-
combinant forms of zebraﬁsh DICP Ig domains bind lipids, which is
a shared characteristic with members of the mammalian CD300
and TREM families of innate immune receptors [9,10].
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2.1. Bioinformatics
Genomic sequences encoding candidate DICP Ig domains were
identiﬁed on zebraﬁsh chromosomes 3, 14 and 16 with BLAST
searches using MDIR and NITR sequences as queries. In silico transla-
tion of each Ig domain indicates that several genes encode a frame
shift or premature stop codon, permitting their classiﬁcation as pseu-
dogenes (Supplemental Materials and methods). Protein sequences
were aligned by Clustal W [11]. Phylogenetic trees were constructed
from pairwise Poisson correction distances with 2000 bootstrap rep-
lications by MEGA5 software [12]. Protein sequence domains were
identiﬁed with SMART software [13].
2.2. DICP transcripts and genes
A small number of DICP ESTs were identiﬁed using BLAST searches of
the zebraﬁsh EST database and those appearing to encode full-length pro-
teinswere sequenced (Supplemental Materials andmethods). Additional
DICP cDNA sequences were obtained by rapid ampliﬁcation of cDNA
ends (RACE) or direct reverse transcriptase-polymerase chain reaction
(RT-PCR) with primers complementing predicted exons (Supplemental
Materials and methods).
2.3. DICP D1–D2 cDNA amplicons from chromosome 3
Partial DICP cDNA sequences were generated using primers
designed to amplify D1–D2-containing DICP genes on chromosome
3. Forward (CATGTGTTCAGCAGWTMTGGAGAAACTG) and reverse
(GATAGACTCCACATCTCCACTGTTTATC) primers were used with Titani-
um Taq (Clontech) to amplify D1–D2 sequences from pooled kidney
and intestine cDNA (zebraﬁsh obtained from EkkWill Waterlife
Resources, Ruskin, FL, USA). Amplicons were cloned into pGEM-T
Easy (Promega) and sequenced.
2.4. Genomic organization
The genomic organization of DICPs was deduced by comparing
cDNA sequences to ZV8 genomic reference sequences: chromosome 3
scaffold 262 (GenBank ID: NW_001878770.2), chromosome 14 scaffold
1719 (GenBank ID: NW_001877436.2) and chromosome 16 scaffold
1952 (GenBank ID: NW_001877662.2). BACs CH73-34H11 (GenBank
ID: FP929011) and CH73-322B17 (GenBank ID: FP015862) were
used to link two unordered segments within scaffold 1952 that
map to chromosome 16.
2.5. Molecular modeling
Theoretical models of DICP D1 domains were generated using the
automated protein homology-modeling server SWISS-MODEL [14].
The Structural Classiﬁcation of Proteins (SCOP) database was utilized
for domain deﬁnitions [15]. The Docker program was used to calcu-
late sequence similarity using the Blosum62 matrix. Figures were gen-
erated with PyMol (The PyMOL Molecular Graphics System, Version
1.2r3pre, Schrödinger, LLC).
2.6. Cloning and expression of hFc chimeras
Recombinant soluble proteins of DICP D1 and D2 ectodomains
fused to a human IgG Fc domain were generated by cloning various
ectodomains (ampliﬁed from pooled hematopoietic tissue cDNA)
into the pcDNA3-hsIgG1Fc-Avi fusion vector [16] that introduces a
N-terminal start codon, signal peptide and a C-terminal human IgG
Fc domain.DICP D1-hFc and D2-hFc chimeric proteins were expressed and
secreted by HEK293T cells. Cells were maintained in RPMI 1640
medium supplemented with 10% fetal bovine serum (FBS), 1 mM sodi-
um pyruvate and 2 mM GlutaMAX (Invitrogen) and transferred to
OPTI-MEM I serum-free medium (Invitrogen) for transfection of hFc
constructs with Lipofectamine 2000 (Invitrogen). Following transfec-
tion, cells were grown for 48 h, pooled, and centrifuged at 500×g for
10 min to clear the supernatant. Recovered supernatants were stored
at 4 °C in 0.02% sodium azide. Supernatant harvests were concentrat-
ed 10 to 100 fold and the hFc fusion proteins were characterized by
Western analyses and quantiﬁed using the Easy-Titer Human IgG
Assay kit (Thermo Scientiﬁc) [16].
2.7. ELISA assay for binding to lipids
Puriﬁed lipids (Sigma and Avanti Polar Lipids) were processed as
described [9]. Solid phase ELISA assays were conducted as described
previously [9]. Either 0.5 μg puriﬁed lipid or 50 μl of MBTE/methanol
bacterial extract was used to coat plates. Negative control wells
were treated in parallel with solvent (100% methanol). Binding efﬁ-
ciency was determined after color development as absorbance at
450 nm. Values were corrected by subtracting the value from negative
control wells.
The effect of concentration on lipid binding of hFc fusion proteins
in the ELISA assay was evaluated. As a positive control, a hFc-fusion of
the Ig domain of murine CLM7, which binds all four puriﬁed lipids
used in screening [9], was employed. CLM7-hFc was added to ELISA
plates at 100 μg/ml (volume 0.10 ml). Dicp1.5529-D1-hFc, which ex-
hibits robust lipid binding, was added at 15 μg/ml (volume 0.10 ml).
The optimal lipid binding exhibited by CLM7-hFc was obtained at 12–
25 μg/ml [9] and assay results were comparable to that of Dicp1.5529-
D1-hFc at 15 μg/ml. The standard concentration of hFc fusion proteins
for assays was 0.10 ml of 10–50 μg/ml.
3. Results and discussion
3.1. Identiﬁcation of DICP Ig domains
A number of approaches exist for identifying immune receptors in
diverse species. We employed a robust series of Ig V-, I- and C2-type
motifs from NITRs and MDIRs as queries in tBLASTn searches of the
zebraﬁsh genome (version Zv8) to identify unrecognized Ig-region
encoding genes and identiﬁed the DICP family. The typical DICP
consists of two distinct classes of extracellular Ig domains: N-terminal
D1 and C-terminal D2 domains, (Figs. 1A–C, Supplemental Figs. S1–
S2). DICP D1 domains share more conserved residues with classical V
domains (G16, V19, L21, C23, W41, L89, I91, D98, G100, Y102, C104) than do
the D2 domains (G16, L21, C23, W41, L89, C104) [17]. Additional pairs of
conserved cysteines: C30 and C87 in D1 and C33 and C85 in D2
(Figs. 1A–B) are predicted to form intrachain disulﬁdes. Twenty-nine
DICP D1 domains were identiﬁed on zebraﬁsh chromosomes 3, 14 and
16 (Fig. 1D). The genes corresponding to the D1 domains are designated
by: a number that denotes the DICP cluster, a number that denotes the
order in which the domains were identiﬁed and a superscript that indi-
cates an allele sequence source, e.g., dicp1.7262: ﬁrst cluster, seventh D1
domain and scaffold 262.
3.2. DICP transcripts
The sequencing of multiple DICP ESTs and cDNAs (Supplemental
Materials and methods and Supplemental Fig. S3) facilitated the char-
acterization of the exon organization and putative translation prod-
ucts from a large number of highly related candidate DICP genes
(Fig. 2). Most DICP D1 domain exons are ﬂanked by exons that encode
a leader signal sequence and a D2 domain exon; dicp2.1 and dicp3.1
284 R.N. Haire et al. / Genomics 99 (2012) 282–291are representative. Several genes are composed of D1 domains that
are adjacent to a predicted leader signal sequence, but lack an appar-
ent D2 domain, (e.g. dicp1.1 and dicp1.9). DICP transcripts encoding a
single D2 domain can be derived through alternative mRNA splicing,
e.g. dicp2.2. Two pairs of contiguous D1–D2 sequences are predicted
to encode proteins with a D1–D2–D1–D2 conﬁguration (dicp1.3-4
and dicp1.5-6; see Supplemental Materials and methods). Based on
the genome assemblies (Fig. 1D), which do not reﬂect the haplotypic
and allelic complexity observed in BAC, EST and cDNA analyses, theA. D1 domains
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285R.N. Haire et al. / Genomics 99 (2012) 282–291identical and 5) alternative mRNA splicing produces a variety of dif-
ferent forms of Dicp1.17, Dicp2.2 andDicp3.1 (Fig. 2 and Supplemental
Fig. S6). It is unclear if dicp3.1 mRNA variation is a result of alternative
splicing or allelic variation as one allele has been identiﬁed that encodes
one copy of exon 5 and a second allele encodes two copies of exon 5 due
to a retrotransposon insertion (Supplemental Fig. S7).
3.3. Predicted functional variation of DICPs
Numerous multigene families of immune receptors include both
inhibitory and activating forms. Inhibitory receptors typically are
associated with cytoplasmic immunoreceptor tyrosine-based inhibi-
tion motifs (ITIMs; S/I/V/LxYxxI/V/L). Activating receptors may pos-
sess cytoplasmic immunoreceptor tyrosine-based activation motifs
(ITAMs; YxxI/Lx(6–12)YxxI/L) or employ a charged residue within
its transmembrane domain that interacts with an ITAM-containing
adaptor protein for signaling [18]. DICP transcripts encoding both
putative inhibitory and activating receptors have been identiﬁed.
Overall, DICPs vary in terms of: 1) number of predicted ectodo-
mains, 2) presence or absence of consensus cytoplasmic ITIMs [19]
or variant ITIMs (itims), 3) number of ITIMs/itims, 4) presence or ab-
sence of C-terminal tyrosine in the cytoplasmic tail, 5) presence or
absence of transmembrane regions, 6) presence or absence of low (se-
quence) complexity regions and 7) presence or absence of charged res-
idues in the transmembrane domain (Fig. 2B). Most DICPs encode
ITIMs/itims and are predicted to be inhibitory. Of theDICPswith deﬁned
coding sequence, none possesses a positively charged transmembrane
residue, a characteristic of activating function in the KIR, Ly49, and
NITR families. However, Dicp2.1 possesses a transmembrane region
with a negatively charged (Glu) residue (GIIIIIEMAALSFPTAILLWIC).This feature is shared with the mammalian activating receptors, CLM-
5 (CD300LD) and CD300c. It has been reported that CLM-5 partners
with and signals via FcRγ [20–22]. Dicp2.1 may partner and signal via
FcRγ or similar adaptor proteins described in zebraﬁsh [23]. Additional
DICP transcripts are predicted to encode secreted proteins with un-
known function. As observed in other families of innate immune recep-
tors (e.g. NITRs, KIRs, Ly49), putative inhibitory forms of DICPs far
outnumber putative activating forms.
3.4. Allelic complexity of DICPs
In order to investigate the variability of DICP transcripts, the D1–
D2 domains of DICP transcripts encoded on chromosome 3 were
ampliﬁed from pooled kidney and intestine cDNAs from zebraﬁsh
obtained from EkkWill Waterlife Resources and sequenced (Fig. 3).
Only two of 15 ampliﬁed sequences represent strong matches to
the reference genomic sequence which is derived from the Tübingen
line of zebraﬁsh (Table 1); speciﬁcally, the peptide sequence en-
coded by cDNA amplicon 2537 matches exactly the predicted Ig do-
mains of Dicp1.5262 and the peptide sequence encoded by
amplicon 2509 differs fromDicp1.6262 by a single residue. D1–D2 do-
mains encoded by two other amplicons, 2530 and 2536, differ from
Dicp1.12262 and Dicp1.16262 by 23 and 33 residues, respectively. Five
other amplicons (2507, 2529, 2532, 2533 and 2534) encode D1 and
D2 domains that share similarity to two different DICP genes: for exam-
ple, amplicon 2529 encodes a D1 that is most similar to the D1 domain
of Dicp1.16262 whereas the D2 domain encoded by this amplicon is
most similar to the D2 domain of Dicp1.11262. Six amplicons (2506,
2508, 2510, 2531, 2535 and 2538) encode DICP sequences (D1 or
D2 or both) that are not present in the reference sequence and
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Fig. 3. DICP D1–D2 cDNA amplicons. Partial DICP cDNA sequences were generated using primers designed to amplify D1–D2-containing DICP genes on chromosome 3. The pre-
dicted protein sequences encoded by amplicons are aligned (sequence ID number is listed on left) with identical residues shaded in black and structurally similar residues shaded
in gray. Primer positions are indicated by arrows below the alignment. Hypervariable (HV) regions and conserved residues characteristic of immunoglobulin domains are indicated
by the IMGT numbering system above the alignments [37]. As many of these peptide sequences do not match the reference genomic sequence, they were not assigned a speciﬁc
gene designation (Table 1).
287R.N. Haire et al. / Genomics 99 (2012) 282–291corresponding sequences currently are not identiﬁable by tBLASTn
searches; four of these (2508, 2510, 2535 and 2538) may represent
new alleles of a single DICP gene. In summary, only one of the ﬁfteen
amplicons is predicted to encode a protein that matches exactly the
reference sequence; most amplicon sequences encode D1–D2 do-
mains that would be divergent (manywith >20 residue differences)
from the reference sequence. This allelic complexity exceeds that
reported previously for NITRs [24].
3.5. DICP D2 domains possess polyserines
Regions of low sequence complexity consisting of variable length
triplet nucleotide repeats, which encode two to 16 residue stretches
of polyserine, are located N-terminal to G16 in D2 (Fig. 1B) andTable 1
Variation of chromosome 3 DICP D1–D2 cDNA amplicons from reference genomic sequence
cDNA amplicon
(GenBank)
Best genomic
reference D1a
Differences with genomic
reference D1b
Gaps with ge
reference D1
2506 (JN416864) Novel n.a. n.a.
2507 (JN416865) Dicp1.12262 9 0
2508 (JN416866) Novel n.a. n.a.
2509 (JN416867) Dicp1.6262 1 0
2510 (JN416868) Novel n.a. n.a.
2529 (JN416869) Dicp1.16262 23 0
2530 (JN416870) Dicp1.12262 20 1
2531 (JN416871) Novel n.a. n.a.
2532 (JN416872) Dicp1.12262 25 1
2533 (JN416873) Dicp1.12262 8 0
2534 (JN416874) Dicp1.16262 23 0
2535 (JN416875) Novel n.a. n.a.
2536 (JN416876) Dicp1.16262 28 0
2537 (JN416877) Dicp1.5262 0 0
2538 (JN416878) Novel n.a. n.a.
a DICP ectodomains encoded by the reference genome sequence (scaffold 262) with the
b Number of amino acid differences between the ectodomains encoded by the cDNA am
c Number of gaps in the alignment between the ectodomains encoded by the cDNA ampcDNAs encoding these regions have been identiﬁed (Fig. 3). This
lower sequence complexity of varying lengths in D2 distinguishes
DICPs from other multigene families of immune-type receptors. Al-
though the functional relevance of polyserine sequences in DICPs is
not yet known, polyserine regions in other proteins have been
reported to serve as ﬂexible linker domains [25], affect polypeptide
stability [26], and separate distinct functional domains [27]. Polyser-
ine stretches are a conserved feature of vitellogenin in invertebrates
and vertebrates [28] and appear to play functional roles in pathogens.
Two such examples are ICP4 of Herpes Simplex Virus 1 [29] and gp40
of Cryptosporidium parvum [30–32]. The polyserine stretches in
DICPs could function in maintaining cell surface receptor integrity
and/or provide steric ﬂexibility in ligand binding or other extracellu-
lar interactions.s.
nomic
c
Best genomic
reference D2a
Differences with genomic
reference D2b
Gaps with genomic
reference D2c
Dicp1.14262 8 0
Dicp1.19262 2 0
Novel n.a. n.a.
Dicp1.6262 0 0
Novel n.a. n.a.
Dicp1.11262 6 0
Dicp1.12262 3 0
Dicp1.11262 6 0
Dicp1.16262 9 0
Dicp1.20262 16 0
Dicp1.11262 5 0
Novel n.a. n.a.
Dicp1.16262 5 0
Dicp1.5262 0 0
Novel n.a. n.a.
highest similarity to DICP cDNA amplicons in Fig. 3.
plicon and the reference sequence.
licon and the reference sequence.
Fig. 4. Structural modeling of Dicp1.6-D1, a predicted V-type Ig domain. (A) A ribbon di-
agram of an atomic homology model of Dicp1.6-D1 is shown in which color variation in-
dicates sequence differences between Dicp1.6-D1 and seven other DICP D1 sequences.
Blosum62 similarity values are: b40, blue, 40–50, cyan, 50–60, green, 60–70, yellow,
70–90, orange and 90–100, red. (B) The front sheet (A′GFCC′C″) of Dicp1.6 is oriented to-
wards the viewer, and depicts the solvent accessible surface. (C and D) The respective rib-
bon and surface prediction models for Dicp1.6-D1, in which the highly conserved back
sheet (ABED) is oriented towards the viewer, are shown. Protein sequence variability is
conﬁned to a single molecular surface.
288 R.N. Haire et al. / Genomics 99 (2012) 282–2913.6. Hypervariable regions in DICP ectodomains
Sequence differences between the D1 and D2 domains are illus-
trated in Figs. 1A–B and 3. The highest degree of sequence variation
(across all DICP reference sequences) in D1 is observed in three hy-
pervariable regions (HV1–HV3); most variation in D2 is localized to
HV1. Notwithstanding the variation in lengths of polyserine stretches,
sequence relatedness between the DICPs that map to chromosome 3
is signiﬁcantly less than that seen for DICP genes that map to chromo-
somes 14 and 16. The overall sequence differences between genes on
chromosome 3 are more regionalized than those on chromosomes 14
and 16. The differences may reﬂect the lower numbers of sequences
being compared for chromosomes 14 and 16 relative to chromosome
3.
3.7. Molecular modeling of DICP D1 domains
Ig domains can be classiﬁed as V-, C1-, C2- or I-type based on the
characteristic distances between the conserved cysteine residues
(C23 C104) that form the B–F disulﬁde bond, a tryptophan residue
(W41) packed against it in the core of the Ig domain fold and overall
strand topology. The intercysteine distance in V-type Ig domains
ranges from 65 to 75 residues and is appreciably shorter in constant
(C) Ig domains (55 to 60 residues) [33]. Intermediate (I-type) Igdomains possess structural features of V domains but exhibit shorter
intercysteine distances [34]. All D1 domains from chromosomes 3
(dicp1 cluster) and 16 (dicp3 cluster) are classiﬁed as V domains by
InterProScan software (release 30.0) [35]. The D1 domains of
Dicp2.1 and Dicp2.2 lack one and two amino acids, respectively,
that are required for classiﬁcation as V domains by InterProScan cri-
teria. Although DICP D2 domains possess the Ig framework residues,
the distance between the conserved cysteine residues is 62 to 64 res-
idues, which could classify them as I-type Ig domains. However, D2
domains are less than 25% identical to solved Ig structures, which is
below the level of similarity that permits homology modeling. Inter-
ProScan software classiﬁes DICP D2 domains as Ig-like.
Atomic homology models of D1 domains from all three gene clus-
ters were generated based on the Protein Data Bank. Dicp1.1262 D1 is
most similar (28% identical) to a V-set domain from the Poliovirus
receptor CD155, (PDB ID: 3eowR). Dicp2.21719 D1 is most similar
(25% identical) to a shark antibody V region, (PDB ID: 1sq2N); how-
ever, Dicp3.11952 D1 is most similar (32% identical) to an I-set Ig do-
main from the FcγrIII receptor, (PDB ID: 1fnlA). Dicp1.6262 D1, which
binds phospholipids (see below), is 25% identical to the V domain of
an antibody light chain, (PDB ID: 2ghwB), and is 32% identical to the I
domain from mouse CNTN4, (PDB ID: 3jxaB). A structural model of
Dicp1.6262 D1 is shown (Fig. 4).
The high degree of variation in chromosome 3 DICP family mem-
bers distributes on the front sheet of the Ig-fold (A′GFCC′C″ strands,
Figs. 4A–B); the back sheet (ABED strands) is predicted to be mini-
mally variant (Figs. 4C–D). In contrast to polymorphic antigen recep-
tors, where sequence variation is clustered on CDR loops, sequence
variations in DICPs are distributed over a broader surface encompass-
ing the front sheet and the CDR3-equivalent loop.
Based on the foregoing criteria, nearly all DICP D1 domains are of
the V type, which is common to many immune receptors. Joining (J)
regions which are conserved features of other V-type receptors such
as Igs, TCRs, some NITRs and a few additional IgSF members (e.g.
CD8), are absent from DICPs. J regions encode the FGXG peptide
motif that facilitates front sheet:front sheet interactions between an-
tigen receptor V domains. V domains that lack the FGXG motif (e.g.
CD2 and CD80) do not dimerize using the front sheet:front sheet in-
terface. Notably, the front sheets of the V domains in CD2 and CD80
participate in ligand binding (CD58 for CD2, CTLA-4 for CD80). DICP
D1 domains are variable at positions that are clustered to a contiguous
solvent exposed surface containing the front sheet F,C,C′ strands and
the Ig-TCR CDR3-analogous FG loop, which we propose may inﬂuence
binding speciﬁcities. Taken together, the sequence comparison and
modeling data suggest that the front sheet of the DICP D1 domains is
used for ligand recognition rather than dimerization.
3.8. DICPS in bony ﬁsh
In order to identify DICP and DICP-related sequences in other
(non-zebraﬁsh) vertebrate species, tBLASTn searches were em-
ployed with DICP D1 and D2 sequences as queries. A small number
of DICP-related sequences were identiﬁed in diverse ﬁsh species
including Cypriniformes (Carp; Cyprinus carpio), Perciformes (tila-
pia; Oreochromis niloticus), Tetraodontiformes (pufferﬁsh: Tetraodon
nigroviridis and Takifugu rubripes), and Salmoniformes (salmon;
Salmo salar) (Supplemental Table S1). Structural features of the
DICP-related proteins were deﬁned by SMART analyses (Supplemental
Fig. S8) and phylogenetic analyses employed to identify non-zebraﬁsh
Ig domains most similar to DICP D1 and D2 domains (Supplemental
Fig. S9). These results demonstrate that: 1) only one deﬁnitive
DICP transcript can be currently identiﬁed outside of zebraﬁsh and
is from the closely related carp (GenBank ID: AB098477), 2) D1-
like and D2-like sequences can be identiﬁed in secreted and mem-
brane bound proteins in tilapia, salmon and pufferﬁsh, 3) a pre-
dicted tilapia transcript (GenBank ID: XM_003458344) possesses
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Fig. 5. DICP Ig domains bind phospholipids. ELISA analysis of interactions of DICP D1-hFc and D2-hFc fusion proteins (Supplemental Fig. S11) with puriﬁed lipids (L), along with
soluble organic extracts from four different classes of bacteria; Gammaproteobacteria (G), Bacilli (B), Actinobacteria (A) and Flavobacterium (F) (Supplemental Table S2). Mouse
CLM7-hFc was included as a positive control [9]. Dicp3.1189-D1-hFc failed to score above background in this assay and is considered a negative control. Corrected ELISA values
less than 0.03 were scored as zero; 0.03–0.05 as +1; 0.05–0.2 as +2; 0.2–0.5 as +3; >0.5 was scored as +4 and are depicted graphically. n.d. = not determined.
289R.N. Haire et al. / Genomics 99 (2012) 282–291two tandem sets of D1-like and transmembrane domains and may
represent two transcripts, 4) the four conserved cysteines in both
D1 and D2 domains (Figs. 1A–B) are present in D1-like and D2-like
domains, but their position varies slightly within the Ig scaffold, 5)
the high level of sequence diversity between zebraﬁsh D1 and D2
domains and the D1-like and D2-like sequences suggest that DICPs
have experienced species-speciﬁc diversiﬁcation and 6) no mam-
malian sequences that are signiﬁcantly similar to DICPs were identi-
ﬁed. In addition, clusters of DICP D1-like sequences can be identiﬁed
in multiple tilapia genomic scaffolds (not shown). These data suggest
that DICPs are encoded by gene clusters in multiple ﬁsh species and
that the DICPs are restricted to bony ﬁsh.
3.9. The chromosome 16 DICP locus shares conserved syntenywith human,
mouse and chicken chromosomal regions encoding FCR/FCRL
Non-DICP genes that are unequivocal orthologs of mammalian
genes and would be useful for evaluating conserved synteny, are
absent from the DICP gene cluster on chromosome 3; however, sev-
eral genes are present at the DICP loci on chromosomes 14 and 16
(Fig. 1D) that can be used to identify regions of conserved synteny
between the zebraﬁsh DICP loci and mammalian IgSF genes. Speciﬁ-
cally, DICP genes on zebraﬁsh chromosome 14 are immediately
ﬂanked by phox2bb and limch1b. Although PHOX2B and LIMCH1 are
tightly linked in humans, mice and chicken, no IgSF gene family
has been identiﬁed near these genes in these species. However,
setdb1b, which is adjacent to the DICP gene cluster on zebraﬁsh chro-
mosome 16, is orthologous to SETDB1 on human chromosome 1q21,
mouse chromosome 3 (F2) and chicken chromosome 25. All of these
chromosomal regions also encode variable numbers of Fc receptor
(FCR) and FCR-like (FCRL) molecules as well as the CD1 gene family
in mouse and human [36]. SETDB1 and the nearest FCR/FCRL gene are
separated by ~1.1 M bp in human, ~0.9 M bp in mouse and ~0.1 M bp
in chicken (Supplemental Fig. S10). Given these considerable mapdistances and large numbers of Ig and adjacent gene loci in vertebrates,
the signiﬁcance of this observation is unclear.3.10. Lipid binding patterns of DICPs
Based on recent observations that MDIRs and certain CD300 and
TREM family members bind lipids [9,10], we investigated the capacity
of DICPs to recognize a variety of lipids including those present in
bacterial extracts. Twenty DICP D1 domains and four D2 domains
were ampliﬁed from cDNA and cloned into a hFc expression vector.
When transfected into mammalian cells, more than half of these con-
structs did not produce soluble protein. In our experience, it is not
uncommon for constructs expressing certain Ig domains to not pro-
duce soluble protein, while other constructs with only small sequence
differences produce protein (Cannon and Haire, unpublished). The
clones corresponding to Dicp1.5-D1, Dicp1.6-D1, Dicp1.14-D1,
Dicp1.16-D1, Dicp1.19-D1, Dicp2.1-D2 and Dicp3.1-D1 successfully
produced secreted, soluble hFc fusion proteins (Supplemental Fig.
S11). Six of the seven D1 and D2 domains in the Fc fusion proteins ei-
ther matched or differed by two residues from the reference peptide
sequence. In contrast, the D1 domain encoded by the Dicp1.14-hFc fu-
sion protein (dicp1.14505) differs from the D1 domain encoded by the
dicp1.14262 reference sequence by 10 residues (two of which repre-
sent an introduced gap); a highly divergent allele of dicp1.14 or a
new DICP gene may account for the differences (Supplemental Fig.
S11). This pattern of sequence diversity is reminiscent of that ob-
served in other DICP cDNA amplicons from chromosome 3 (Fig. 3).
In enzyme-linked immunosorbent assays (ELISAs) for lipid bind-
ing, the DICP hFc fusion proteins exhibit a range of lipid binding spec-
iﬁcity (Fig. 5). The D1 domain of Dicp1.5 binds to lipids and bacterial
extracts (Supplemental Table S2) and is very robust (ELISA scores
of +3 or +4 for 11 of 24 lipid sources). The D1 domains of Dicp1.6
and Dicp1.16 along with the D2 domain of Dicp2.1 exhibit moderate
290 R.N. Haire et al. / Genomics 99 (2012) 282–291binding (ELISA scores of +2 to +4 for 6 of 24 lipid sources). The D1
domain of Dicp1.14 displays moderate binding to lipid extracts only
frommycobacteria (ELISA scores of +1, +2 and +4). The D1 domain
of Dicp1.19 exhibits weak binding to 7 of 24 lipid sources with only
one ELISA score greater than +1. The D1 domain of Dicp3.1189 did
not bind lipids or bacterial extracts in this assay. Dicp1.5529-D1,
which binds robustly, and Dicp1.6533-D1, which binds moderately,
differ by six residues. Although this is a small data set, no clear se-
quence motif was identiﬁed as essential for lipid binding. For exam-
ple, the D1 domain of Dicp3.1, which did not bind lipids in this
assay, shares the same core Ig domain residues with the other D1
domains that bound lipids (Supplemental Fig. S11). Identiﬁcation
of residues required for lipid binding is further confounded by the
sequence differences in the HV regions between the domains that
do and do not bind lipids. In addition, no restriction for DICP binding
to extracts from speciﬁc classes of bacteria (Gammaproteobacteria,
Bacilli, Actinobacteria and Flavobacteria) was observed. The func-
tional implications of lipid binding by DICPs remain to be resolved.
3.11. Summary
With the exception of bony ﬁsh NITRs that may function as NK
receptors [3], the function of many large families of Ig-containing re-
ceptors (with unknown ligands) identiﬁed throughout the vertebrate
radiations remains unclear. Recently, it has been shown that the dif-
ferential binding of lipids by members of the mammalian CD300
and TREM gene families is a general feature of this group of molecules
and potentially is related to their overall function [9]. Multiple DICP Ig
domains described here exhibit a similar capacity to bind free lipid
and lipid extracts of different bacteria, including pathogens, suggest-
ing that lipid binding groups the DICPs and CD300/TREMmolecules at
a functional level.
The predicted inhibitory and activating functions of DICPs and
their chromosomal organization in distinct loci along with evidence
for retroviral-based transposition, underscore similarities between
DICPs with NITRs. Furthermore, nearly all DICPs possess potential O-
glycosylation sites in their membrane-proximal extracellular regions,
which is a characteristic of MDIRs and CD300 molecules. However,
the minimum level of overall sequence relatedness does not support
a common origin for these gene families.
These ﬁndings raise important questions regarding the origins of
multigene families encoding Ig domain activating/inhibitory pro-
teins in vertebrates. It appears as if Ig, TCR and FcR (including FcRL)
exhibit ubiquitous distribution throughout the bony ﬁsh, amphib-
ians, reptiles, birds and mammals. CD300/TREM-like molecules, in
which we tentatively have grouped MDIRs [8], are distributed in
cartilaginous ﬁsh, bony ﬁsh and other vertebrates, although the
depth of annotation is not comparable to that in mammals. Given
the ﬁndings reported here, it appears as if far more complex families
of Ig domain-encoding cell surface molecules are found in lower
vertebrates than inmammals (as has been reported for other Ig encod-
ing families, e.g., avian and amphibian species encode far more
putative FcRs than mammals). Given our superior understanding of
a large number of vertebrate genomes, it is increasingly more likely
that the distributions of DICPs and NITRs may well be restricted to
the teleost ﬁsh.
The mechanisms whereby multigene families (e.g. DICPs and
NITRs) arise and expand are of fundamental interest. Notably,
most current reference ﬁsh species are egg-laying with ex utero em-
bryonic development. The immunological “needs” of such species
may be unique and potentially exceed those of ovoviviparous ﬁsh
species. Some of the questions raised along these lines likely can
be settled with forthcoming genome sequences of representative
species of this latter group as well as the resolution of holostean,
and chondrichthyan as well as the genomes of crosspterygian and
sarcopterygian ﬁsh species. Regardless of the speciﬁc mechanismby which DICPs and NITRs arose and expanded, their wide spread pres-
ence in, but simultaneous restriction to, a single large phylogenetic
group of vertebrates (the bony ﬁsh) emphasizes the highly plastic
and dynamic nature of immune molecules.
Supplementary materials related to this article can be found online
at doi:10.1016/j.ygeno.2012.02.004.Acknowledgments
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